Selenious Acid Injection, USP is now available as a 12mcg/2mL (6mcg/mL of selenium) single-dose vial designed for pediatric and neonatal patients who weigh less than 7kg.

Selenious Acid Injection is a trace element indicated in adult and pediatric patients as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. Prior to administration, Selenious Acid Injection must be transferred to a separate parenteral nutrition container, prepared and used as an admixture in parenteral nutrition solutions.

Selenious Acid Injection is supplied as 12mcg/2mL (6mcg/mL of selenium) single-dose vials and 600mg/10mL (60mg/mL of selenium) pharmacy bulk package vials; both products are preservative-free. 

“We are pleased to add the 12mcg/2mL (6mcg/mL) single-dose vial of Selenious Acid to our family of FDA-approved products. Both Selenious Acid products available from American Regent have been developed to align with the American Society for Parenteral and Enteral Nutrition (ASPEN) Dosing Recommendations for trace elements supplementation,” said Joann Gioia, Vice President and Chief Commercial Officer at American Regent, Inc. 


  1. American Regent announces the launch of Selenious Acid Injection, USP in a 12 mcg/2 mL single-dose vial. News release. American Regent, Inc. March 31, 2022. Accessed April 1, 2022.
  2. Selenious Acid Injection. Package insert. American Regent, Inc.; 2022. Accessed April 1, 2022.